Both PI5P4Kα and PI5P4Kβ are involved in p53-deficient breast cancer and soft tissue sarcomas22,23 and high expression of both PI5P4Kα and PI5P4Kγ associate with unfavourable clinical outcome in AML.24 The gene discussed is PIP4K2A; the disease is breast carcinoma.